What is Genitourinary Syndrome of Menopause? Explained Simply

Genitourinary syndrome of menopause (GSM) is the medical term for the physical changes that happen to the vulva, vagina, and lower urinary tract after estrogen levels fall. It is a chronic, progressive condition — not a temporary phase — and it affects a large share of postmenopausal women. The term replaced older labels like “vaginal atrophy” because it better reflects that symptoms involve both the genital and urinary systems.

GSM is caused by reduced estrogen, which thins and dries the vaginal tissue and changes the urinary tract. It does not go away on its own. Safe, effective treatments exist, but many women never mention their symptoms to a clinician — often because of embarrassment or because they assume nothing can be done.

What Causes Genitourinary Syndrome of Menopause?

The cause is a drop in estrogen. Estrogen receptors are found throughout the vagina, vulva, urethra, and bladder. When estrogen falls — after menopause, or sometimes during other hormonal changes — these tissues lose some of their usual support.

The vagina normally has a thick, moist lining and a slightly acidic environment maintained by healthy bacteria. Estrogen helps sustain both. Without it, the lining thins, natural lubrication decreases, and the tissue becomes less elastic. The acidity shifts, which can change the vaginal microbiome.

The same process affects the urinary tract. The urethra and bladder also depend partly on estrogen to stay healthy. This is why GSM can cause urinary symptoms, not just vaginal ones.

GSM can also occur during other times of low estrogen. It is most common after menopause, but it can happen with certain treatments that lower estrogen, such as some breast cancer therapies. It is not caused by poor hygiene, sexual activity, or anything a woman did wrong.

What Are the Symptoms of Genitourinary Syndrome of Menopause?

Symptoms fall into two groups: genital and urinary. Many women have both, and the pattern varies widely from person to person.

Genital symptoms can include:

• Vaginal dryness and a feeling of irritation or burning
• Reduced lubrication during sex
• Discomfort or pain with sexual activity
• Itching or a raw feeling around the vulva
• Less natural elasticity in the vaginal tissue

Urinary symptoms can include:

• A sudden, strong urge to urinate
• Urinating more often than usual
• Burning or discomfort when urinating
• Recurrent urinary tract infections
• Some leakage of urine

One point that surprises many women: these symptoms are not always linked to how much estrogen a woman has lost, and they can appear or worsen at any point after menopause — sometimes years later. Some women notice symptoms early; others develop them gradually over time.

The symptoms are often underreported. Many women assume dryness or urinary changes are simply a normal part of aging to be endured. They are common after menopause, but they are a recognized medical condition with treatment options.

How Is Genitourinary Syndrome of Menopause Diagnosed?

GSM is usually diagnosed through a conversation and a physical exam. There is no single blood test that confirms it.

A clinician will ask about symptoms — dryness, irritation, pain with sex, urinary changes — and about when menopause occurred. During a pelvic exam, a clinician may look for visible signs such as thinning tissue, reduced moisture, and paleness or redness of the vaginal lining.

Because urinary symptoms can overlap with other conditions, a clinician may check for a urinary tract infection or other causes. This matters. A urinary tract infection and GSM can produce similar symptoms, and sometimes both are present at once.

There is no routine lab test that diagnoses GSM on its own. Diagnosis rests on symptoms plus exam findings, after other causes are considered.

What Treatments Are Available for Genitourinary Syndrome of Menopause?

Several treatments can reduce symptoms. They range from over-the-counter moisturizers to prescription estrogen. Which one fits depends on a woman’s symptoms, health history, and preferences.

Non-hormonal options include:

• Vaginal moisturizers, used regularly to add moisture to the tissue
• Lubricants, used at the time of sexual activity to reduce discomfort
• Staying sexually active, which some evidence suggests can help maintain tissue health

Prescription options include:

• Low-dose vaginal estrogen, available as a cream, tablet, or ring. This delivers estrogen locally to the vaginal tissue. It is the most studied treatment for GSM and is generally considered effective for vaginal symptoms.
• Oral hormone therapy, which some women use for menopause symptoms more broadly. Whether it helps GSM specifically depends on the individual and should be discussed with a clinician.
• Other prescription therapies, such as a selective estrogen receptor modulator (ospemifene) for certain women, and a vaginal dehydroepiandrosterone (DHEA) product. These are options a clinician may discuss.

A few honest points about evidence. Low-dose vaginal estrogen has a solid track record for relieving vaginal dryness and discomfort. Its effect on urinary symptoms is less consistent across studies, though some research suggests benefit for recurrent urinary tract infections. The evidence for non-hormonal moisturizers is real but generally weaker than for vaginal estrogen.

There is a common misconception worth correcting: low-dose vaginal estrogen is not the same as systemic hormone therapy. It works mainly in the local tissue, and the amount that reaches the bloodstream is very low. This distinction matters when discussing risks with a clinician, but it does not mean it is risk-free for everyone. Women with a history of certain hormone-sensitive cancers, unexplained vaginal bleeding, or other specific conditions should discuss any estrogen product with their clinician first.

No single treatment works for everyone. Some women respond well to moisturizers alone; others need prescription therapy. Many use a combination. The right approach is a conversation with a clinician who knows the person’s history.

Can Genitourinary Syndrome of Menopause Be Prevented?

GSM cannot be fully prevented, because it follows from a natural drop in estrogen that most women experience. But its impact can be reduced, and symptoms can be managed well.

Regular vaginal moisturizer use can help maintain tissue comfort. Lubricants can make sexual activity more comfortable. Staying sexually active, when desired, may help maintain tissue flexibility. None of these stop the underlying hormonal change, but they can ease its effects.

The most important step is not to wait. Symptoms tend to progress over time if untreated. Women who bring up symptoms early often have more options and better results than those who wait years. If dryness, irritation, pain with sex, or urinary changes are affecting daily life, that is a reason to talk to a clinician — not something to push through silently.

Why Do So Many Women Not Get Help?

Embarrassment and misinformation are the main barriers. Many women are uncomfortable raising vaginal or urinary symptoms. Others assume the changes are an unavoidable part of aging and that nothing can be done.

Neither is accurate. GSM is a recognized condition, and effective treatments exist. The gap between how common GSM is and how often it is treated is well documented in menopause research.

There is also a language problem. Because older terms like “vaginal atrophy” focused only on the vagina, many women did not connect their urinary symptoms to menopause at all. The newer term, genitourinary syndrome of menopause, was adopted precisely to capture both the genital and urinary sides of the condition — and to make clear it is a syndrome worth naming and treating.

If a clinician does not bring it up, women can. A simple statement — “I’m having dryness and urinary changes since menopause” — is enough to start the conversation.